Institute for Data Science in Oncology

Top

Bringing the power of data science to every decision we make

Scroll Ahead

Harnessing the power of data. Transforming personalized medicine.

MD Anderson’s Institute for Data Science in Oncology (IDSO) will harness the power of data and bring data science to every decision we make – accelerating the pace to end cancer and improve the lives of cancer patients and their families.

The institute is dedicated to enabling the full power of data science. By achieving meaningful integration of diverse data, IDSO seeks to not only derive new insights but to use them through advanced, data-driven approaches and decision-making. Ultimately, this will lead to advancing drug discovery efforts and bringing new, precise medicines to patients sooner, improving scheduling and access to care, enhancing safety and quality of care, and reducing the time between diagnostic procedures and treatment decisions.

Transforming insights into impact

The institute fosters an ecosystem for our clinicians, researchers and a growing team of data scientists to pioneer the use of data science to explore new frontiers in cancer research and care. But exploration is not enough. IDSO seeks impact for our patients. By design, IDSO supports data science-enabled insights that can be put into practice, thereby transforming cancer care for our patients and the world.

For the next five years, five areas of focus will drive impactful change. Each was chosen for their readiness and potential for impact, and is co-led by newly recruited MD Anderson faculty, with recruitment underway for several other co-leads.

David Jaffray, Ph.D.

Chief Technology and Digital Officer & Senior Vice President

MD Anderson Cancer Center

We need to use next generation computational technologies and approaches to aid what our minds alone can't realize to reach potentials unknown.

Data science advances cancer care and research

IDSO plays a key role in the next phase of MD Anderson's history. The institute uses data science to generate clinically meaningful insights from complex and vast quantities of data that can be brought directly to our patients. IDSO will ensure pace and progress toward our mission to end cancer.

Read the full story